Selective regulation of p38β protein and signaling by integrin-linked kinase mediates bladder cancer cell migration

L Yu1, X Yuan2, D Wang1

  • 1Centre for Cancer Research, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia.

Oncogene
|February 26, 2013
PubMed

Insights

Integrin-linked kinase (ILK) regulates p38β protein levels, crucial for bladder cancer cell migration and actin organization. ILK inhibition affects p38β stability and downstream Hsp27 activation.

Area of Science:

  • Cell biology
  • Molecular oncology
  • Biochemistry

Background:

  • Integrin-linked kinase (ILK) and p38 mitogen-activated protein kinase (MAPK) pathways regulate cell migration and cytoskeleton.
  • Dysregulation of ILK and p38(MAPK) signaling is implicated in bladder cancer progression.
  • Specific p38 isoforms in ILK-regulated responses remain underexplored.

Purpose of the Study:

  • Investigate the relationship between ILK and p38 isoforms in bladder cancer.
  • Elucidate the role of ILK-p38β signaling in bladder cancer cell migration and cytoskeletal organization.
  • Identify downstream targets of ILK-p38β signaling.

Main Methods:

  • RNA interference (RNAi) for gene knockdown.
  • Western blotting and quantitative real-time PCR (qRT-PCR) for protein and mRNA analysis.
  • Co-precipitation, bimolecular fluorescent complementation (BiFC), and in situ proximity ligation assays (PLA) for protein interactions.
  • Proteasomal inhibition assays.
  • Cell migration and actin cytoskeleton assays.
  • Pharmacological inhibition of ILK.

Main Results:

  • A strong positive correlation exists between ILK and p38β protein levels in bladder cancer tissues.
  • ILK knockdown selectively reduces p38β protein levels, independent of mRNA expression, and this is partially rescued by proteasomal inhibition.
  • ILK and p38β form cytoplasmic complexes, and their serum-stimulated assembly is inhibited by a small molecule ILK inhibitor.
  • ILK inhibition reduces serum-induced activation of heat shock protein 27 (Hsp27), a p38β target.

Conclusions:

  • ILK plays a critical role in regulating p38β protein stability and cellular levels in bladder cancer cells.
  • ILK-p38β signaling complexes are essential for Rac1-dependent cell migration and actin cytoskeletal organization.
  • Hsp27 is identified as a novel downstream target of ILK-p38β signaling in bladder cancer cell migration.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...